Quest Diagnostics Elects Director
News Jan 14, 2014
Tim Main currently serves as Chairman of the Board of Directors for Jabil Circuit, Inc.. Mr. Main joined Jabil in April 1987 and served in a number of operations and business development roles before being appointed Chief Executive Officer in September 2000, a role he held until 2013. As CEO, Mr. Main led Jabil's growth strategy, increasing annual revenues nearly fivefold to reach $17 billion in 2012, and expanding in Asia and other emerging markets.
"Tim has an exceptional record of generating business growth and shareholder value in a competitive, complex global market," said Steve Rusckowski, President and CEO, Quest Diagnostics. "This experience, coupled with his deep understanding of operations and supply chain management, will enable him to share a fresh, compelling perspective on Quest as we execute our strategy to restore growth, drive operational excellence and deliver disciplined capital deployment."
Daniel C. Stanzione, Ph.D., Chairman of the Board of Directors of Quest Diagnostics, added: "As the Chairman and former CEO of a large multinational with an operations-intensive business, Tim Main brings expertise in strategy, operations, and corporate governance that will be helpful to our company. We are pleased to welcome him to the Quest Board."
Mr. Main earned a B.S. degree from Michigan State University and Master of International Management degree from the American Graduate School of International Management (Thunderbird).
Potential Barcode Identified for a Form of Alcoholic Liver DiseaseNews
NIAAA-supported researchers have discovered that extracellular vesicles released by liver cells in a mouse model of alcoholic steatohepatitis contain a miRNA signature detectable in the blood.READ MORE
Enterome and Nestlé Health Sciences Launch New Diagnostics CompanyNews
Enterome and Nestlé Health Sciences join to create Microbiome Diagnostics Partners, a company that will enable the development and diagnostics for multiple diseases including inflammatory bowel diseases (IBD) and liver diseases.READ MORE